CLPT

ClearPoint Neuro Inc. Common Stock (CLPT)

Stock · NASDAQ · Health Care

$9.08as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

CLPT Featured in Pre-Market Movers. ClearPoint Neuro (CLPT) was highlighted in pre-market lists for Tuesday, indicating notable trading activity before the open. The stock is currently trading near its 52-week low of $8.27 and has shown a volume spike. While analyst targets remain significantly higher at an average of $23.50, the recent price action suggests heightened volatility and interest from traders.

Active signals

Resistance level
$14.24
Industry
Medical/Dental Instruments

What CLPT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike38-3.1%42%
Bollinger Band Breakout24-1.2%50%
Bollinger Band Breakdown19+0.9%53%
200-Day Moving Average TouchActive now14-1.1%29%
Any 20-session window (baseline)-2.1%44%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About CLPT

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
160

Fundamentals

1-day range
$9$9.6
Market cap
$408.45M
P/E (trailing)
—
P/E (forward)
-7.59
EPS (trailing)
$-1.18
Dividend yield
—
Beta
1.30
Avg. volume
664.3K
Dividend pay date
July 27, 2016
52-week range
$8.27$28.1
Next earnings: October 28, 2026 · EPS estimate $-0.31confirmed

How ClearPoint Neuro Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$36.97MSG&A$16.50M (45%)Cost of Revenue$14.28M (39%)R&D$13.90M (38%)Tax$55.0K (0%)CLPT

Source: 10-K filed Mar 17, 2026 · via SEC EDGAR / Finnhub

Gross Profit$22.69M(61%)
Operating Income-$24.16M(-65%)

Forecasts

2 analyst ratings

Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$25
+175.5%
Median
$23.5
+159.0%
Low
$22
+142.4%

ClearPoint Neuro Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • CLPT
    ClearPoint Neuro Inc. Common Stock
    $9.07
    ▼ 5.91%
    Market cap $408.45MP/E —
    $8.27$28.1
  • MOBI
    Mobia Medical Inc. Common Stock
    $8.09
    ▼ 2.65%
    Market cap $409.63MP/E —
    $8.16$15.29
  • OFIX
    Orthofix Medical Inc. Common Stock (DE)
    $9.38
    ▼ 2.19%
    Market cap $428.47MP/E —
    $8.5$16.99
  • SGHT
    Sight Sciences Inc. Common Stock
    $8.28
    ▼ 5.91%
    Market cap $385.77MP/E —
    $3.34$9.71
  • CARL
    Carlsmed Inc. Common Stock
    $13.41
    ▼ 3.87%
    Market cap $372.43MP/E —
    $8.5$17.23
  • SI
    Shoulder Innovations Inc. Common Stock
    $18.09
    ▼ 1.52%
    Market cap $465.16MP/E —
    $10.92$24.6
  • CERS
    Cerus Corporation Common Stock
    $2.18
    ▼ 3.54%
    Market cap $467.54MP/E —
    $1.38$3.47

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
99.4K
Disposed
82.2K
  • Richards Timothy T. · October 1, 2026 · Grant
    319 @ $12.21
  • R. John Fletcher · October 1, 2026 · Grant
    993 @ $12.21
  • BURNETT JOSEPH · September 2, 2026 · Option Exercise
    12.5K @ $3.47
  • Richards Timothy T. · July 1, 2026 · Grant
    222 @ $17.84
  • R. John Fletcher · July 1, 2026 · Grant
    662 @ $17.84
  • STIGALL L. JEREMY · June 30, 2026 · Grant
    1.8K @ $11.93
  • D'Alessandro Danilo · June 30, 2026 · Grant
    1.1K @ $11.93
  • BURNETT JOSEPH · June 30, 2026 · Grant
    1.4K @ $11.93
  • BURNETT JOSEPH · June 29, 2026 · Option Exercise
    20.0K @ $2.5
  • BURNETT JOSEPH · June 29, 2026 · Sale
    20.0K @ $19.38
  • BURNETT JOSEPH · June 17, 2026 · Option Exercise
    60.0K @ $2.5
  • BURNETT JOSEPH · June 17, 2026 · Sale
    1.8K @ $17.94
  • BURNETT JOSEPH · June 17, 2026 · Sale
    60.0K @ $17.79
  • Richards Timothy T. · June 4, 2026 · Option Exercise
    500 @ $10
  • Richards Timothy T. · June 4, 2026 · Tax Withholding
    376 @ $13.3

Institutional Ownership

March 31, 2026

Total shares held
13.00M
Total value held
$114.67M
Institutional holders
117
Top holders this quarter
  • Unknown2.08M
  • Unknown1.90M
  • Unknown1.24M
  • Unknown705.7K
  • Unknown679.8K
  • Unknown486.8K
  • Unknown463.6K
  • Unknown451.5K
  • Unknown432.4K
  • Unknown372.4K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.